跳至主要内容
临床试验/NCT06026345
NCT06026345招募中不适用

The Affera Global Registry is a Prospective, Global, Multi-center, Observational Post-market Registry (PMR)

Medtronic Cardiac Ablation Solutions12 个研究点 分布在 7 个国家目标入组 540 人开始时间: 2023年12月22日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
540
试验地点
12
主要终点
Primary Objective #1 (Efficacy)

研究概览

简要总结

The Affera Global Registry is a prospective, global, multi-center, observational post-market registry (PMR). The purpose of this study is to describe clinical performance and safety data in a broad patient population treated with the Affera Platform.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject is ≥ 18 years of age or minimum age as required by local regulations
  • Planned procedure using the commercially available Affera Platform
  • Willing and able to comply with study requirements and give IC (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this clinical study) or authorization per institution and geographical requirements

排除标准

  • Subject is enrolled in a concurrent study that has not been approved for concurrent enrollment by the global study manager
  • Subject with exclusion criteria required by local law

结局指标

主要结局

Primary Objective #1 (Efficacy)

时间窗: 12 Month Post Proceedure

Estimate freedom from recurrence of the arrhythmia(s) treated at the study index ablation procedure using the Affera Platform.

次要结局

  • Primary Objective #2 (Safety)(90 Days Post Proceedure)

研究者

发起方
Medtronic Cardiac Ablation Solutions
申办方类型
Industry
责任方
Sponsor

研究点 (12)

Loading locations...

相似试验